ZYMEWORKS INC. Other Comprehensive Income (Loss), Net of Tax
ZYMEWORKS INC. (ZYME) reported Other Comprehensive Income (Loss), Net of Tax of $720.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-08.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2023-05-08
- ZYMEWORKS INC. other comprehensive income (loss), net of tax for the quarter ending 2023-03-31 was $720.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month |
|---|---|
| 2023-03-31 | $720.00K 10-Q · filed 2023-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |